Johnson & Johnson settles opioid case in New York, will pay up to $230 million and stop selling deadly drugs in US
Johnson & Johnson has agreed to cough up a settlement of up to $230 million and stop selling opioids in the US. The sum is a drop in the ocean for the firm, but comes as nationwide trials could see …